Chemoprevention Therapy Plus Surgery in Treating Women With Breast Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Breast Cancer
In brief
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of fenretinide and tamoxifen before surgery may be an effective way to prevent the recurrence of or further development of breast cancer. PURPOSE: Randomized phase II trial to study the effectiveness of fenretinide and tamoxifen given before surgery in treating women with breast cancer.
Key facts
- Study ID
- NCT00003099
- Run by
- M.D. Anderson Cancer Center
- People needed
- 52
- Starts
- 1996-05-01
- Expected to finish
- 2003-01-01
- Last updated by the study team
- 2012-07-30
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
Where it is running
- University of Texas - MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.